Regulations.gov document
Guidance for Industry on Antiviraf Product Development-Conducting and Submitting Virology…
Notice · FDA-2005-D-0282 · posted Jun 5, 2006
Key facts
| Document ID | FDA-2005-D-0282-0005 |
|---|---|
| Title | Guidance for Industry on Antiviraf Product Development-Conducting and Submitting Virology Studies to the Agency ; Availability |
| Document type | Notice |
| Subtype | NAD-Notice of Availability of Data |
| Agency | FDA |
| Docket | FDA-2005-D-0282 |
| Posted | Jun 5, 2006 |
| Comment period opens | Jun 2, 2006 |
| Comments due | Jun 5, 2007 |
At a glance
- None Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: